Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients

Clinical trial NCT05817903 · RECRUITING

Trial details

NCT number: NCT05817903
Sponsor: Consorzio Oncotech
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma

Start date: 2023-04-18
Primary completion: 2026-04-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.